Rath S, Elamarthi P, Parab P, Gulia S, et al. Efficacy and safety of palbociclib and ribociclib in patients with estrogen
and/or progesterone receptor positive, HER2 receptor negative metastatic breast
cancer in routine clinical practice. PLoS One 2021;16:e0253722.
PMID: 34292933